tiprankstipranks
Neuren Pharmaceuticals Limited (NURPF)
OTHER OTC:NURPF

Neuren Pharmaceuticals Limited (NURPF) Financial Statements

25 Followers

Neuren Pharmaceuticals Limited Financial Overview

Neuren Pharmaceuticals Limited's market cap is currently ―. The company's EPS TTM is $0.815; its P/E ratio is 16.90; Neuren Pharmaceuticals Limited is scheduled to report earnings on August 27, 2024, and the estimated EPS forecast is $0.13. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19Dec 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 40.18MAU$ 36.78MAU$ 24.19MAU$ 13.84MAU$ 23.58M
Total AssetsAU$ 43.27MAU$ 40.06MAU$ 24.95MAU$ 14.41MAU$ 26.64M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -40.18MAU$ -36.78MAU$ -24.19MAU$ -13.84MAU$ -23.58M
Total LiabilitiesAU$ 1.68MAU$ 803.00KAU$ 753.00KAU$ 559.00KAU$ 1.97M
Stockholders EquityAU$ 41.59MAU$ 39.25MAU$ 24.20MAU$ 13.85MAU$ 24.67M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Neuren Pharmaceuticals Limited Earnings and Revenue History

Neuren Pharmaceuticals Limited Debt to Assets

Neuren Pharmaceuticals Limited Cash Flow

Neuren Pharmaceuticals Limited Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis